108 related articles for article (PubMed ID: 2279297)
1. Synthesis of a thymosin beta 4-like peptide, thymosin beta Met9, and its effect on low E-rosette-forming lymphocytes of lupus nephritis patients.
Abiko T; Sekino H
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2301-4. PubMed ID: 2279297
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a thymosin beta 4-like peptide, deacetyl-thymosin beta Xen4, and its restorative effect on depressed lymphocyte blastogenic response to phytohemagglutinin (PHA) in uremic patients.
Abiko T; Sekino H
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2467-71. PubMed ID: 2605693
[TBL] [Abstract][Full Text] [Related]
3. Effects of synthetic thymosin beta 9 fragments on low E-rosette-forming cells of lupus nephritis patients.
Abiko T; Sekino H
J Appl Biochem; 1983 Dec; 5(6):446-52. PubMed ID: 6236194
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase syntheses of two deacetyl-thymosin alpha 1 analogues with substitution at position 21 and their effects on low E-rosette-forming lymphocytes of uremic patients.
Abiko T; Sekino H
Biotechnol Ther; 1992; 3(3-4):159-68. PubMed ID: 1303729
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of deacetyl-thymosin beta 12 and examination of its immunological effects on the impaired T and B lymphocytes in uremic patients.
Abiko T; Sekino H
Biotechnol Ther; 1993; 4(3-4):221-37. PubMed ID: 8292971
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of rat parathymosin alpha fragment 1-28 and examination of its inhibitory activity towards the restoring activity of thymosin alpha 1 on the impaired T-lymphocytes of uremic patients.
Abiko T; Sekino H
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2647-52. PubMed ID: 1806285
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of six common amino acid sequence fragments of thymosins beta 4, beta 8 and beta 9 and determination of their effects on the low E-rosette forming cells of lupus nephritis patients.
Abiko T; Sekino H
Chem Pharm Bull (Tokyo); 1984 Jan; 32(1):228-36. PubMed ID: 6722950
[No Abstract] [Full Text] [Related]
8. The synthesis of peptides with potential thymic hormone activity: the synthesis of endo-Arg38a-deacetylthymosin beta 10.
Abiko T; Sekino H
Biotechnol Appl Biochem; 1987 Feb; 9(1):20-30. PubMed ID: 3494463
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of deacetylthymosin beta 11 and its effect on the impaired T-lymphocytes of a uremic patient with common variable immunodeficiency.
Abiko T; Sekino H
Biotechnol Appl Biochem; 1988 Dec; 10(6):576-88. PubMed ID: 3266074
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a new biological response modifier thyrnosin beta(4) analogue and its restorative effect on depressed.
Abiko T; Sekino H
Mediators Inflamm; 1992; 1(2):113-9. PubMed ID: 18475450
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of prothymosin alpha deduced from nucleotide sequence of the murine cDNA and its effect on the impaired T lymphocytes of uremic patients.
Abiko T; Sekino H
Biotechnol Ther; 1993; 4(3-4):213-20. PubMed ID: 8292970
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of the nonatriacontapeptide corresponding to the entire amino acid sequence of calf thymosin beta 8 and its effect on the impaired T-cell subsets in patients with lupus nephritis.
Abiko T; Sekino H
Chem Pharm Bull (Tokyo); 1983 Apr; 31(4):1320-9. PubMed ID: 6605205
[No Abstract] [Full Text] [Related]
13. Solid-phase synthesis of biologically active fragment 29-111 of rat prothymosin alpha.
Abiko T; Sekino H
Biotechnol Appl Biochem; 1991 Jun; 13(3):406-11. PubMed ID: 1883531
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of human splenin (hSP) and examination of its immunological effects on the impaired T- and B-lymphocytes in uremic patients.
Abiko T; Sekino H
Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):487-91. PubMed ID: 2337963
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and immunological effect of deacetyl-thymosin alpha 11 on low E-rosette-forming cells of a rheumatoid arthritis patient.
Abiko T; Sekino H
Chem Pharm Bull (Tokyo); 1985 Dec; 33(12):5419-27. PubMed ID: 3833387
[No Abstract] [Full Text] [Related]
16. Interaction of G-actin with thymosin beta 4 and its variants thymosin beta 9 and thymosin beta met9.
Jean C; Rieger K; Blanchoin L; Carlier MF; Lenfant M; Pantaloni D
J Muscle Res Cell Motil; 1994 Jun; 15(3):278-86. PubMed ID: 7929793
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of [Glu34]human splenin (hSP) and examination of its immunological effect on the reduced B-lymphocytes of uremic patients.
Abiko T; Sekino H
Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):391-6. PubMed ID: 2787213
[TBL] [Abstract][Full Text] [Related]
18. Effect of two thymosin fraction 5 polypeptides on human peripheral blood lymphocytes.
Kokkinopoulos D; Perez S; Baxevanis C; Papamichail M
Immunopharmacol Immunotoxicol; 1987; 9(4):409-19. PubMed ID: 2893819
[TBL] [Abstract][Full Text] [Related]
19. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of thymosin beta 9 Met from pork spleen.
Hannappel E; Wartenberg F; Bustelo XR
Arch Biochem Biophys; 1989 Sep; 273(2):396-402. PubMed ID: 2774558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
